Fundraising FoxCodon Capital — Full Portfolio
3 tracked investments · listed companies and verified rows first
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)
Co-investorsCarbon SiliconCerberus VenturesDauntless VenturesFifty YearsJude GomilaMetaplanet+12 more
Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.
BiotechHealthtechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inNeela Patel(Executive Officer)inDiane Hollenbaugh(Executive Officer)in
BoardSamuel Bjork(Director)inMonique Schiersing(Director)inJohn McKearn(Director)in
Co-investorsRiverVest Venture PartnersRoche Venture FundVivo Capital3x5 PartnersDigitalis Ventures
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.
BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US
Sasan Amini(Founder)inRamin Khaksar(Founder)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)
Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+13 more
Portfolio company acquired by Roche.
BiotechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)
BoardJohn McKearn(Director)inKarl Handelsman(Director)
Co-investorsDigitalis VenturesRiverVest Venture Partners3x5 PartnersRoche Venture Fund
Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics.
AgTechBiotechEmeryville, US
Alvin Tamsir(Founder)inKarsten Temme(Founder)inAlvin Tamsir, Ph.D.(Chief Science Officer & Co-Founder)Karsten Temme, Ph.D.(Chief Innovation Officer and Co-Founder)Chris Abbott(Chief Executive Officer)in
BoardRoger Wyse(Director)in
Co-investorsBreakthrough Energy VenturesCongruent VenturesDCVC (Data Collective)G2 Venture PartnersK3 VenturesK3V Ventures+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.